vitiligo. Vitiligo
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Suffering from vitiligo Stability of lesions for at least 3 months Less than 20 percent of skin involvement Having symmetrical lesions
Exclusion criteria
Exclusion criteria: Generalized or progressive vitiligo pregnancy or lactation any history of allergy to Curcumin patients who are resistant to other vitiligo therapies such as immunomodulators drugs , photo-therapy and etc. any malignancy or active skin infections
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Size of lesions. Timepoint: at baseline and 1,2,3 and 4 months after using the drug. Method of measurement: imagej application.;Notice ability of lesions. Timepoint: at the end of the study. Method of measurement: Vitiligo Noticeability Scale Questionnaire.;Percentage of re-pigmentation. Timepoint: at baseline and 1,2,3 and 4 months after using the drug. Method of measurement: taking photo under wood lamp. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life score in patients with vitiligo. Timepoint: before initiation of treatment and after finishing it. Method of measurement: Vitiligo Quality of Life Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Islamic Azad University